[go: up one dir, main page]

PE20070125A1 - Moduladores no esteroides de receptor de progesterona - Google Patents

Moduladores no esteroides de receptor de progesterona

Info

Publication number
PE20070125A1
PE20070125A1 PE2006000733A PE2006000733A PE20070125A1 PE 20070125 A1 PE20070125 A1 PE 20070125A1 PE 2006000733 A PE2006000733 A PE 2006000733A PE 2006000733 A PE2006000733 A PE 2006000733A PE 20070125 A1 PE20070125 A1 PE 20070125A1
Authority
PE
Peru
Prior art keywords
alkyl
methyl
progesterone receptor
receptor modulators
benzoxazin
Prior art date
Application number
PE2006000733A
Other languages
English (en)
Spanish (es)
Inventor
Ulrich Bothe
Peter Droescher
Ulrike Fuhrmann
Alexander Hillisch
Guenter Kaufmann
Carsten Moller
Norbert Schmees
Wolfgang Schwede
Lothar Sobek
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of PE20070125A1 publication Critical patent/PE20070125A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/536Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines ortho- or peri-condensed with carbocyclic ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/24Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/34Gestagens
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D265/00Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/021,2-Oxazines; Hydrogenated 1,2-oxazines

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Gynecology & Obstetrics (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
PE2006000733A 2005-06-24 2006-06-26 Moduladores no esteroides de receptor de progesterona PE20070125A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE102005030292A DE102005030292A1 (de) 2005-06-24 2005-06-24 Nichtsteroidale Progesteronrezeptor-Modulatoren

Publications (1)

Publication Number Publication Date
PE20070125A1 true PE20070125A1 (es) 2007-02-14

Family

ID=37199176

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2006000733A PE20070125A1 (es) 2005-06-24 2006-06-26 Moduladores no esteroides de receptor de progesterona

Country Status (22)

Country Link
EP (1) EP1902049A2 (no)
JP (1) JP2008543910A (no)
KR (1) KR20080030622A (no)
CN (1) CN101248066A (no)
AR (1) AR054519A1 (no)
AU (1) AU2006261048A1 (no)
BR (1) BRPI0611903A2 (no)
CA (1) CA2611897A1 (no)
CR (1) CR9598A (no)
DE (1) DE102005030292A1 (no)
DO (1) DOP2006000148A (no)
EA (1) EA200702524A1 (no)
EC (1) ECSP078044A (no)
GT (1) GT200600271A (no)
IL (1) IL188021A0 (no)
MX (1) MX2008000072A (no)
NO (1) NO20080440L (no)
PE (1) PE20070125A1 (no)
TW (1) TW200740778A (no)
UY (1) UY29624A1 (no)
WO (1) WO2006136461A2 (no)
ZA (1) ZA200800690B (no)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UY30805A1 (es) * 2006-12-21 2008-07-31 Bayer Schering Pharma Ag Moduladores no esteroides de receptores de progesterona
DE102007032800A1 (de) * 2007-07-10 2009-01-15 Bayer Schering Pharma Aktiengesellschaft Nichtsteroidale Progesteronrezeptor-Modulatoren
DE102007058747A1 (de) * 2007-12-05 2009-06-10 Bayer Schering Pharma Aktiengesellschaft Nichtsteroidale Progesteronrezeptor-Modulatoren
JP2011519916A (ja) * 2008-07-02 2011-07-14 ファーマコステック カンパニー リミテッド アミド誘導体の製造方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19856475A1 (de) * 1998-11-27 2000-05-31 Schering Ag Nichtsteroidale Entzündungshemmer
EP1344776A1 (en) * 2002-03-11 2003-09-17 Schering Aktiengesellschaft 5- 2-hydroxy-3-[1-(3-trifluoromethylphenyl)-cyclopropyl]-propionylamino -phtalide and 6- 2-hydroxy-3-[1-(3-trifluoromethylphenyl)-cyclopropyl]-propionylamino -4-methyl-2,3-benzoxazin-1-one derivatives with progesterone receptor modulating activity for use in fertility control, hormone replacement therapy and the treatment of gynecological disorders
RS20050974A (sr) * 2003-07-01 2007-09-21 Schering Aktiengesellschaft, Heterociklično supstituisani pentanol-derivati,postupak za njihovo dobijanje i njihova primena kao supresora zapaljenja

Also Published As

Publication number Publication date
EA200702524A1 (ru) 2008-06-30
IL188021A0 (en) 2008-03-20
DOP2006000148A (es) 2007-07-15
CR9598A (es) 2008-04-09
EP1902049A2 (en) 2008-03-26
UY29624A1 (es) 2007-01-31
MX2008000072A (es) 2008-03-24
KR20080030622A (ko) 2008-04-04
TW200740778A (en) 2007-11-01
ECSP078044A (es) 2008-01-23
ZA200800690B (en) 2009-09-30
DE102005030292A1 (de) 2007-01-11
GT200600271A (es) 2007-02-05
BRPI0611903A2 (pt) 2010-10-05
JP2008543910A (ja) 2008-12-04
NO20080440L (no) 2008-03-25
CN101248066A (zh) 2008-08-20
AR054519A1 (es) 2007-06-27
CA2611897A1 (en) 2006-12-28
AU2006261048A1 (en) 2006-12-28
WO2006136461A2 (en) 2006-12-28
WO2006136461A3 (en) 2007-03-15

Similar Documents

Publication Publication Date Title
AR058005A1 (es) Derivados fluorados de 4-(2- amino-1-hidroxietil) fenol como agonistas del receptor beta 2 adrenergico
PE20071022A1 (es) Compuestos derivados de dibencilamina como inhibidores de la proteina de transferencia del colesteril ester (cept)
PE20081679A1 (es) Compuestos del inhibidor de fosfoinositida 3-cinasa y metodos de uso
DE602005016775D1 (de) Heterocyclische, ein azol enthaltende sulfonamidinhibitoren der beta-amyloid-produktion
PE20141375A1 (es) Activadores de glucoquinasa
AR054814A1 (es) Derivados de piridazina
PE20081530A1 (es) Nuevos compuestos 617
AR050691A1 (es) Compuestos de isoindolona como potenciadores del receptor metabotropico de glutamato. procesos de obtencion y composiciones farmaceuticas.
PE20090218A1 (es) Compuestos mimeticos de glucocorticoides, metodos de preparacion y composiciones farmaceuticas
DK1912979T3 (da) Phenyl-{3-{3-(1H-pyrrol-2-YL)-[1,2,4]oxadiazol-5-YL]piperidin-1-YL}-methanon-derivater og beslægtede forbindelser som positive allosteriske modulatorer af metabotrope glutamat-receptorer
PE20091952A1 (es) Compuestos de tiazole y oxazole de sulfonamida de benzeno
PE20120790A1 (es) 2-mercaptoquinolin-3-carboxamidas sustituidas como moduladores de kcnq2/3
AR055150A1 (es) Compuestos de isoindol - imido y composiciones que los comprenden y sus metodos de uso
PE20081532A1 (es) Compuestos novedosos
PE20080677A1 (es) Inhibidores de pirrolotriazina cinaza
AR071385A1 (es) Compuestos de 2-imino-3-metil pirrolopirimidinona sustituida con tiofenilo,composiciones farmaceuticas que los contienen,y uso de los mismos para el tratamiento de patologias asociadas con la proteina beta amiloide,tales como alzheimer y otros formas de demencia.
PE20140868A1 (es) Antagonistas trpm8 y su uso en tratamientos
AR075084A1 (es) Metodo de preparacion de quinolinil -oxidifenil - ciclopropanodicarboxamidas e intermediarios correspondientes
CO6231008A2 (es) Fenoxi tiazolidindionas sustituidas como moduladores del receptor alfa relacionado con el estrogeno
PE20120113A1 (es) Nuevos derivados de benzotiadiazepinas, su procedimiento de preparacion y composiciones farmaceuticas que los contienen
PE20110875A1 (es) Derivados de isoindol como inhibidores de bace
PE20091102A1 (es) Moduladores imidazolo-, oxazolo-, y tiazolopirimidina del trpv1
PE20070495A1 (es) COMPUESTOS DERIVADOS DE alfa-AMINOCARBOXIAMIDA CUATERNARIOS COMO MODULADORES DE LOS CANALES DE SODIO CON APERTURA POR VOLTAJE
PE20090655A1 (es) Derivados de 2-aza-biciclo[2.2.2]octano para prevencion o tratamiento de psicosis
PE20091524A1 (es) Derivados de 2-aminopirimidina

Legal Events

Date Code Title Description
FD Application declared void or lapsed